As shown in Figure 9D–F, MAPK4 expression was significantly positively correlated with expression of the main immunoinhibitory checkpoint molecules PD‐1, PD‐L1, HAVCR2, PDCD1LG2 and TIGIT in glioma. The gene discussed is MAPK4; the disease is central nervous system cancer.